CN105732747A - Abamectin oil deep processing method - Google Patents
Abamectin oil deep processing method Download PDFInfo
- Publication number
- CN105732747A CN105732747A CN201610156129.0A CN201610156129A CN105732747A CN 105732747 A CN105732747 A CN 105732747A CN 201610156129 A CN201610156129 A CN 201610156129A CN 105732747 A CN105732747 A CN 105732747A
- Authority
- CN
- China
- Prior art keywords
- abamectin
- ointment
- reaction
- paste
- avilamycin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
Abstract
The invention discloses an abamectin oil deep processing method and belongs to organic chemical synthesis of the chemical synthesis field.The abamectin oil deep processing method includes subjecting abamectin oil to abamectin oil pretreatment, protection reaction, oxidizing reaction, amination reduction reaction, deprotection reaction and salt forming reaction so as to obtain a mixture of abamectin B2a amino derivative salts and abamectin B1a amino derivative salts.The abamectin oil deep processing method changing a utilizing way of existing abamectin oil has the advantages that refining and crystallizing technological steps are decreased in synthesis processing, further preparation processing is facilitated greatly, higher safety and more environment friendliness are achieved, and unnecessary farmland pollution and subsequent preparation processing cost are reduced effectively.
Description
Technical field
The invention belongs to the organic chemical synthesis in the field of chemical synthesis, specifically a kind of Ah
The deep processing processing method of the leftover bits and pieces abamectin ointment of dimension rhzomorph.
Background technology
Avilamycin is to be produced by Sterptomyces avermitills, belongs to Lycoperdon polymorphum Vitt strepto-
Bacterium.Last century, the eighties, public with Merck by Japan's university scientific Jia great village, North intelligence etc.
Department's joint development, fermented extraction process produces.Merck company therefrom extracts one group to be had
The mixture of the homologue composition that eight structures are similar, and by its named avilamycin.
Avilamycin is a hexa-atomic macrolide antibiotics of class ten, in its structure, sixteen-ring
Lactone and disaccharide oleandrose form glucosides, and with hexa-atomic Spiroketals system and hexahydro benzo furan
It is connected for muttering.Avilamycin is the mixture of natural fermented component, total A1a、A2a、B1a、
B2a、A1b、A2b、B1b、B2Eight kinds of component compositions of b;A1a、A2a、B1a、B2A tetra-kinds is main
Composition total content >=80%, corresponding four kinds of composition A1b、A2b、B1b、B2B content is less, always
Content≤20%.
Avilamycin is a kind of never poison, and its mechanism is to act on insect neuron synapse or god
Through the GABA receptor of muscle synapse, the information of interference insect nerves within the body tip is transmitted, the most sharp
The non-tip of going crazy releases neurotransmission inhibitor Y--aminobutyric acid (GABA), promotes GABA door
The chloride channel of control extends open, has activation, a large amount of chloride ion to chloride channel
Pour in and cause neural membrane potentials hyperpolarization, cause neurolemma to be in inhibitory state, thus block god
Through contacting of the non-tip and muscle, make insect paralysis, refusing to eat, death.Because its mechanism of action is unique,
So with conventional medicament no interactions resistance.Insecticide and snail class are had and tag and stomach poison function,
But can not ovicidal, have broad-spectrum high efficacy, resist resistance, lasting period length, low toxicity, low-residual,
Degradable, on natural enemy little, the safety high of impact.
Avilamycin is present in the mycelium of fermentation liquid, discards filtrate through filtering, and filter cake is used
Through desaccharide after ethanol extraction, concentrate, crystallize available avilamycin fine work (containing AbamectinB1
95%), the mother solution after crystallization through be evaporated under reduced pressure be concentrated into solvent-free after add toluene or dimethylbenzene it
The organic solvent of class obtains abamectin ointment after being formulated into appointment viscosity, wherein avilamycin
B1The content of a typically (i.e. contains AbamectinB between 3~9%13%~9%).
The world today is along with people's call to pollution-free food, biological pesticide and semi-synthetic biological agriculture
Medicine demonstrates its importance day by day;Artificial semi-synthetic biological pesticide is increasingly by the weight of people
Depending on.Avilamycin carries out deep processing, and artificial semi-synthetic Avermectins pesticide has obtained people
Common recognition.But in published patent or non-patent literature, no matter to avilamycin B1a
Deep processing still to avilamycin B2The deep processing of a none be not with avilamycin series fine powder
Process the most abroad through row research and development, the deep processing to abamectin ointment for parent
Or the domestic blank field of still genus;The present invention intends by the main component in abamectin ointment
B2A and B1A performs the derivatization synthesis and becomes salt that abamectin ointment is carried out deep processing process.
Summary of the invention:
The present invention changes the utilization ways of existing abamectin ointment, it is provided that a kind of new Ah
The deep processing processing method of dimension rhzomorph ointment, makes synthesis processing decrease refining crystallization technique step
Suddenly, make further preparation processing simpler, convenient;More safe and environment-friendly;More add and subtract
Few unnecessary farmland pollution and the processing cost of follow-up preparation.
A kind of deep processing processing method of the abamectin ointment of the present invention, through the following steps that
Carry out:
One, the pretreatment of abamectin ointment
(1) avilamycin commodity ointment is mixed homogeneously in the ratio of quality 20~22: 1 with water
After be evaporated under reduced pressure, remove contained solvent, obtain the paste of abamectin ointment;
(2) in gained paste, in mass ratio 1: 1 addition petroleum ether and stirring dissolves paste,
Static layering, removes contained oils and fats in ointment;
(3) mass percent that quality is above-mentioned petroleum ether quality 20% it is added thereto to again
Concentration is the solution of trichloroacetic acid of 10%, stirs, static layering, removes in ointment contained
Protein;
(4) again surplus solution is evaporated under reduced pressure, removes contained solvent, obtain paste;
Two, protection reaction
Dichloromethane is added molten by avilamycin paste and dichloromethane mass volume ratio 1: 2
Solving paste, after paste is completely dissolved, cooling system temperature, to-20 DEG C~-15 DEG C, is dripped
Add the bright ester of chloro-carbonic acid alkene and tetramethylethylenediamine solution carry out protection and reacts, response time 2h,
Notice that system temperature must not be higher than-15 DEG C, by B in ointment2A and B1The C of a5Position hydroxyl is carried out
Protection;
Three, oxidation reaction
After protection reaction completes, dissolve abamectin ointment B with isopropyl acetate2A and B1A's
C5Position hydroxyl protection thing, in mass ratio 1: 10: 3: 3 add abamectin ointment B2A and B1A's
C5Position hydroxyl protection thing, dimethyl sulfoxide, four Shen base ethylenediamines, phenyl phosphate carry out oxidation instead
Should, keep system temperature-20 DEG C~-15 DEG C, response time 2h, after having reacted, obtain Ah
The B of dimension rhzomorph ointment2A and B1A 4 " position keto compounds;
Four, amination reduction reaction
(1) after oxidation reaction completes, by the B of abamectin ointment2A and B1A 4 " position ketone group
Oxide is dissolved in isopropyl acetate, and in mass ratio 2: 5: 1 add the B of abamectin ointment2a
And B1" position ketone group oxide, heptamethyldisilazane, that trifluoroacetic acid zinc carries out amination to a 4 is anti-
Should, heat up and keep system temperature 40 DEG C~60 DEG C, response time 2h, obtaining after having reacted
C to amination5The B of position hydroxyl protection2A and B1A 4 " position imido grpup derivant;
(2) after aminating reaction completes, reduction system temperature to-10 DEG C~-15 DEG C, add nothing
Water-ethanol and borane reducing agent sodium hydride, response time 1h, obtain avilamycin after having reacted
The B of ointment2A and B1a C5The methylamino derivant of position protection;
Five, deprotection reaction
By the B of abamectin ointment2A and B1a C5The methylamino derivant of position protection is dissolved in anhydrous
In ethanol, keep reacting liquid temperature-5 DEG C, after response time 1h, reacting liquid temperature is heated up
To 30 DEG C, keeping 1h, use ethanol extraction reactant after having reacted, precipitation obtains Avermectin
The B of vegetable oil cream2A and B1The methylamino derivant of a.
Six, salt-forming reaction
(1) B of abamectin ointment is pressed2A and B1The methylamino derivant of a and benzoic acid matter
Amount is reacted than 2: 1 ratios, and response time 1h obtains avilamycin B after having reacted2a
Amido derivative salt and avilamycin B1The mixture of a amido derivative salt;
(2) after question response is fully completed, it is evaporated under reduced pressure obtaining solution, treats that solvent steams
After Faing, add and obtain paste quality 40% toluene and 0.3%BHT, i.e. obtain Avermectin
Element avilamycin B2The amido derivative salt of a and avilamycin B1The mixing of a amido derivative salt
Thing.
Beneficial effect
The present invention changes the utilization ways of existing abamectin ointment, it is provided that a kind of new Ah
The deep processing processing method of dimension rhzomorph ointment, makes synthesis processing decrease refining crystallization technique step
Suddenly, make further preparation processing simpler, convenient;More safe and environment-friendly;More add and subtract
Few unnecessary farmland pollution and the processing cost of follow-up preparation.
Detailed description of the invention
It is described in detail below by way of specific embodiment, but scope not office
It is limited to following illustrated embodiment.
Embodiment 1: the deep processing processing method of a kind of abamectin ointment of present embodiment is
Carried out by following steps:
One, the pretreatment of abamectin ointment
(1) in 500ml flask, avilamycin commodity ointment 120g (B1a content is added
8.6%), it is evaporated under reduced pressure after the 6g that adds water mixing, removes contained solvent, obtain the Ah of paste
Dimension rhzomorph ointment 70g;
(2) the abamectin ointment 70g of gained paste, is added thereto to petroleum ether 70g and stirs
Mix the abamectin ointment dissolving paste, static layering, remove contained oils and fats in ointment;
(3) trichlorine that mass percent concentration is 10% that quality is 14g it is added thereto to again
Acetic acid solution, stirs, static layering, removes protein contained in ointment;
(4) again surplus solution is evaporated under reduced pressure, removes contained solvent, obtain paste;
Two, protection reaction
Molten by the avilamycin paste 68g after precipitation adds dichloromethane 130g stirring again
Xie Hou, cools to-20 DEG C, drips allyl chlorocarbonate 3g, tetramethylethylenediamine 2.5g, instead
After answering 2h, terminating reaction, precipitation obtains abamectin ointment B2A and B1The C of a5Position hydroxyl
Protection intermediate;
Three, oxidation reaction
Abamectin ointment B2A and B1The C of a5It is different that position hydroxyl protection intermediate 60g is dissolved in acetic acid
In propyl ester solution, add dimethyl sulfoxide 4g, tetramethyl different diamidogen 5g, cool to-20 DEG C, drip
Add phenyl phosphate 4g, with the pH to 2.0~3.0 of acid solution regulation solution, response time
2h, terminates reaction, collects dichloromethane phase, regulates pH to 7.0 with alkaline solution, then
Dichloromethane is removed in decompression, obtains Simultaneous Oxidation product Intermediate;
Four, amination reduction reaction
(1) Simultaneous Oxidation product 57g and the isopropyl acetate 200g obtained stirring is mixed,
Add trifluoroacetic acid zinc 1g and heptamethyldisilazane 4g mix homogeneously, be then warmed up to
50 DEG C, react 3h, obtain aminate;
(2) after aminating reaction terminates, reaction system is cooled to-10 DEG C, to the amine obtained
Change and product adds dehydrated alcohol 100g, add borane reducing agent sodium hydride 2g, must mix molten
Liquid, reacts 1h, the pH to 3.0 of regulation mixed solution, terminates reaction, then use alkaline solution
Regulation mixed solution pH to 7.0, obtains isopropyl acetate and extracts reactant liquor, and reduce pressure precipitation,
Obtain C5The abamectin ointment B of position hydroxyl protection2A and B1The methylamino product of a;
Five, deprotection reaction
To the C obtained5The abamectin ointment B of position hydroxyl protection2A and B1The methylamino product of a
Middle addition dehydrated alcohol, cools to-5 DEG C, adds triphenylphosphine 0.001g, sodium borohydride
0.01g, reacts 1h, adds hydrochloric acid and adjusts PH to 3, be then warmed up to 30 DEG C, reacts 1h,
After reaction terminates, after decompression precipitation, i.e. obtain abamectin ointment B2A and B1A methylamino derivant
Salt 46g.
Six, salt-forming reaction
At the 46g abamectin ointment B obtained2A and B1A methylamino derivative salt adds matter
Amount 18g toluene and 0.13gBHT, i.e. obtain avilamycin avilamycin B2The amido derivative of a
Salt and avilamycin B1The mixture of a amido derivative salt.
Embodiment 2: the deep processing processing method of a kind of abamectin ointment of present embodiment is
Carried out by following steps:
One, the pretreatment of abamectin ointment
(1) in 5L reactor, avilamycin commodity ointment 1200g (B1a content is added
8.6%), the 60g that adds water is evaporated under reduced pressure after being uniformly mixed, and removes contained solvent,
Abamectin ointment to paste;
(2) the abamectin ointment 700g of gained paste, is added thereto to petroleum ether 700g
The abamectin ointment of stirring and dissolving paste, static layering, remove contained oils and fats in ointment;
(3) trichlorine that mass percent concentration is 10% that quality is 140g it is added thereto to again
Acetic acid solution, stirs, static layering, removes protein contained in ointment;
(4) again surplus solution is evaporated under reduced pressure, removes contained solvent, obtain paste;
Two, protection reaction
Molten by the avilamycin paste 680g after precipitation adds dichloromethane 130g stirring again
Xie Hou, cools to-20 DEG C, drips allyl chlorocarbonate 30g, tetramethylethylenediamine 25g, instead
After answering 2h, terminating reaction, precipitation obtains abamectin ointment B2A and B1The C of a5Position hydroxyl
Protection intermediate;
Three, oxidation reaction
Abamectin ointment B2A and B1The C of a5Position hydroxyl protection intermediate 600g is dissolved in acetic acid
In isopropyl ester solution, add dimethyl sulfoxide 40g, tetramethyl different diamidogen 50g, cool to-20
DEG C, drip phenyl phosphate 40g, regulate the pH to 2.0~3.0 of solution with acid solution, instead
2h between Ying Shi, terminates reaction, collects dichloromethane phase, regulates pH to 7.0 with alkaline solution,
Then dichloromethane is removed in decompression, obtains Simultaneous Oxidation product Intermediate;
Four, amination reduction reaction
(1) Simultaneous Oxidation product 570g and the isopropyl acetate 2000g obtained stirring is mixed,
Add trifluoroacetic acid zinc 10g and heptamethyldisilazane 40g mix homogeneously, then heat up
To 50 DEG C, react 3h, obtain aminate;
(2) after aminating reaction terminates, reaction system is cooled to-10 DEG C, to the amine obtained
Change and product adds dehydrated alcohol 1000g, add borane reducing agent sodium hydride 20g, obtain mixing
Solution, reacts 1h, the pH to 3.0 of regulation mixed solution, terminates reaction, more molten by alkalescence
Liquid regulation mixed solution pH to 7.0, obtains isopropyl acetate and extracts reactant liquor, and reduce pressure precipitation,
Obtain C5The abamectin ointment B of position hydroxyl protection2A and B1The methylamino product of a;
Five, deprotection reaction
To the C obtained5The abamectin ointment B of position hydroxyl protection2A and B1The methylamino product of a
Middle addition dehydrated alcohol, cools to-5 DEG C, adds triphenylphosphine 0.01g, sodium borohydride 0.1g,
Reaction 1h, adds hydrochloric acid and adjusts PH to 3, be then warmed up to 30 DEG C, react 1h, and reaction terminates
After, i.e. obtain abamectin ointment B after decompression precipitation2A and B1aMethylamino derivative salt 460g;
Six, salt-forming reaction
At the 460g abamectin ointment B obtained2A and B1A methylamino derivative salt adds matter
Amount 180g toluene and 1.3gBHT, i.e. obtain avilamycin avilamycin B2The amido derivative of a
Salt and avilamycin B1The mixture of a amido derivative salt.
Claims (1)
1. the deep processing processing method of an abamectin ointment, it is characterised in that: include with
Lower step:
One, the pretreatment of abamectin ointment:
(1) ratio of avilamycin commodity ointment with water in mass ratio 20~22: 1 is mixed all
It is evaporated under reduced pressure after even, removes contained solvent, obtain paste abamectin ointment;
(2) in mass ratio 1: 1 addition petroleum ether and stirring in gained paste abamectin ointment
Dissolve paste abamectin ointment, static layering, remove contained oil in paste abamectin ointment
Fat;
(3) adding quality again in the product of step (2) is the stone described in step (2)
The solution of trichloroacetic acid that mass percent concentration is 10% of oil ether quality 20%, stirs,
Static layering, removes protein contained in ointment;
(4) again surplus solution is evaporated under reduced pressure, removes contained solvent, obtain paste;
Two, protection reaction: by avilamycin paste and dichloromethane mass volume ratio 1: 2
Add dichloromethane and dissolve paste, after paste is completely dissolved, cooling system temperature to-20
DEG C~-15 DEG C, dropping the bright ester of chloro-carbonic acid alkene and tetramethylethylenediamine solution carry out protection reaction,
Response time 2h, notices that system temperature must not be higher than-15 DEG C, by B in ointment2A and B1A's
C5Position hydroxyl is protected;
Three, oxidation reaction: after protection reaction, dissolve abamectin ointment with isopropyl acetate
B2A and B1The C of a5Position hydroxyl protection thing, in mass ratio 1: 10: 3: 3 add Avermectin vegetable oil
Cream B2A and B1The C of a5Position hydroxyl protection thing, dimethyl sulfoxide, tetramethylethylenediamine, phosphoric acid
Phenyl ester carries out oxidation reaction, keeps system temperature-20 DEG C~-15 DEG C, response time 2h, instead
The B of abamectin ointment should be obtained after completing2A and B1A 4 " position keto compounds;
Four, amination reduction reaction:
(1) after oxidation reaction completes, by the B of abamectin ointment2A and B1A 4 " position ketone group
Oxide is dissolved in isopropyl acetate, and in mass ratio 2: 5: 1 add the B of abamectin ointment2a
And B1" position ketone group oxide, heptamethyldisilazane, that trifluoroacetic acid zinc carries out amination to a 4 is anti-
Should, heat up and keep system temperature 40 DEG C~60 DEG C, response time 2h, obtaining after having reacted
C to amination5The B of position hydroxyl protection2A and B1A 4 " position imido grpup derivant;
(2) after aminating reaction completes, reduction system temperature to-1 DEG C~-15 DEG C, add anhydrous
Ethanol and borane reducing agent sodium hydride, response time 1h, obtain Avermectin vegetable oil after having reacted
The B of cream2A and B1a C5The methylamino derivant of position protection;
Five, deprotection reaction: by the B of abamectin ointment2A and B1a C5The methylamine of position protection
Radical derivative is dissolved in dehydrated alcohol, keeps reacting liquid temperature-5 DEG C, after response time 1h,
Reacting liquid temperature is warmed up to 30 DEG C, keeps 1h, after having reacted, use ethanol extraction reactant,
Precipitation obtains the B of abamectin ointment2A and B1The methylamino derivant of a.
Six, salt-forming reaction:
(1) B of abamectin ointment is pressed2A and B1The methylamino derivant of a and benzoic acid matter
Amount is reacted than 2: 1 ratios, and response time 1h obtains avilamycin B after having reacted2a
Amido derivative salt and avilamycin B1The mixture of a amido derivative salt;
(2) after question response is fully completed, it is evaporated under reduced pressure obtaining solution, treats that solvent steams
After Faing, add and obtain paste quality 40% toluene and 0.3%BHT, i.e. obtain Avermectin
Element avilamycin B2The amido derivative salt of a and avilamycin B1The mixing of a amido derivative salt
Thing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610156129.0A CN105732747B (en) | 2016-03-11 | 2016-03-11 | A kind of deep processing processing method of abamectin ointment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610156129.0A CN105732747B (en) | 2016-03-11 | 2016-03-11 | A kind of deep processing processing method of abamectin ointment |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105732747A true CN105732747A (en) | 2016-07-06 |
CN105732747B CN105732747B (en) | 2018-09-18 |
Family
ID=56250830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610156129.0A Active CN105732747B (en) | 2016-03-11 | 2016-03-11 | A kind of deep processing processing method of abamectin ointment |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105732747B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116237084A (en) * | 2022-12-10 | 2023-06-09 | 河北兴柏农业科技股份有限公司 | Supported zinc trifluoroacetate, preparation method and application |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103030675A (en) * | 2012-11-19 | 2013-04-10 | 河北威远生物化工股份有限公司 | Process of extracting abamectin components B1 and B2 step by step by utilizing crystallization method |
CN103214532A (en) * | 2013-02-28 | 2013-07-24 | 河北威远生物化工股份有限公司 | Avermectin B2a/2b amine derivatives, derivative salts thereof, and preparation method and application of avermectin B2a/2b amine derivative salt |
CN103421065A (en) * | 2013-07-03 | 2013-12-04 | 大庆志飞生物化工有限公司 | Novel Avermectin derivative and preparation method thereof |
CN104497081A (en) * | 2014-05-14 | 2015-04-08 | 孟水强 | Macrolide benzoate compound and application thereof |
-
2016
- 2016-03-11 CN CN201610156129.0A patent/CN105732747B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103030675A (en) * | 2012-11-19 | 2013-04-10 | 河北威远生物化工股份有限公司 | Process of extracting abamectin components B1 and B2 step by step by utilizing crystallization method |
CN103214532A (en) * | 2013-02-28 | 2013-07-24 | 河北威远生物化工股份有限公司 | Avermectin B2a/2b amine derivatives, derivative salts thereof, and preparation method and application of avermectin B2a/2b amine derivative salt |
CN103421065A (en) * | 2013-07-03 | 2013-12-04 | 大庆志飞生物化工有限公司 | Novel Avermectin derivative and preparation method thereof |
CN104497081A (en) * | 2014-05-14 | 2015-04-08 | 孟水强 | Macrolide benzoate compound and application thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116237084A (en) * | 2022-12-10 | 2023-06-09 | 河北兴柏农业科技股份有限公司 | Supported zinc trifluoroacetate, preparation method and application |
Also Published As
Publication number | Publication date |
---|---|
CN105732747B (en) | 2018-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103214532B (en) | Avermectin B2a/2bAmido derivative, derivative salt and avermectin B2a/2bThe Preparation method and use of amido derivative salt | |
EP3261634B1 (en) | Mixtures of cannabinoid compounds, their preparation and use | |
EP3041815A1 (en) | Mixtures of cannabinoid compounds, and production and use thereof | |
CN104497081A (en) | Macrolide benzoate compound and application thereof | |
CN101879158A (en) | New application of artemisinin derivant | |
CN103360308A (en) | 1,4-dyhydroxy-6-methyl-2-pyridine ketone compound, and preparation method and use thereof | |
CN105732747A (en) | Abamectin oil deep processing method | |
CN104904721B (en) | A kind of microbicide compositions and preparation and its application | |
CN106831662B (en) | A kind of amido polyol is for fumidil and its synthetic method and application | |
CN107709335A (en) | Kakeromycin and its derivative manufacture method | |
CN102893988B (en) | Diethyl aminoethyl hexanoate mineral oil missible oil composition and application | |
CN102060895A (en) | Method for desugaring abamectin | |
CN107556276A (en) | C triaryl glucoside compounds and its preparation method and application | |
CN106889085A (en) | A kind of pure-natural biological composition kills fire ant bait agent and preparation method thereof | |
CN106135234B (en) | Application of (substituted-amino formyl the methylthiol) -1,3,4- thiadiazole compounds of 2,5- bis- in inhibiting blue algae growth | |
CN106866710A (en) | Ultrasonic wave one kettle way prepares pyrazoles sulfonamides sodium, potassium, the method for calcium metal complex and application | |
CN106588581A (en) | Stilbenes derivative and application thereof | |
DE3831465A1 (en) | BASIC CLEAVAGE PRODUCTS OF ELAIOPHYLIN AND ELAIOPHYLIN DERIVATIVES AND THE USE THEREOF | |
CN105153260B (en) | A kind of C21Pregnane analog derivative and its preparation method and application | |
CN109134218A (en) | Ingredient 4- oxo-trans- 2- hexenoic aldehyde synthetic method is lured in a kind of fleahopper sex pheromone | |
CN108047163A (en) | A kind of preparation method of Repaglinide | |
CN111303092B (en) | 2, 4-dinitro-6-chloroaniline derivative, synthetic method and application thereof | |
CN106008545B (en) | The compound salt derivative of Norcantharidin and its antitumor application thereof | |
Ghochikyan et al. | Study of the biological properties of semi-and thiosemicarbazones of carbonyl derivatives of 4-butanolides | |
CN108558764A (en) | N- [(6- halogen -1H- indazole -1- bases) alkyl] -2- amino acids and the preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |